Catégorie : [:fr]Audio anglais[:en]Audio in English
Nathalie Garcon 3

(Audio-EN) Bioaster, Neomed : Same Objective, Similar Approach, Some Differences

Montreal (QUEBEC) – Nathalie Garçon is the CEO and CSO of Bioaster, a French technological research institute dedicated to work on infectious diseases and microbiology sponsored jointly by Lyonbiopôle and l’institut Pasteur. On Thursday the 25th of February, she gave a lecture at the Neomed Institute wich is summarized in this interview. She explains why […]


(Audio-EN) Can financial engineering cure cancer ?

Montreal (QUEBEC) – No, financial engineering cannot cure cancer, but it can get more fundings to the people that might be able to develop therapies that are really effective. Roger Stein’s lecture at the NÉOMED Institute, Thursday the 5th of November, which is summarized in this interview, explains how his new model that uses modern […]

2 Terrence Kenakin nouvel essai blog neomed 2

(audio-EN) You thought you knew everything about receptors? You may learn a new concept with Terrence Kenakin

Montreal (QUEBEC) – Dr Terrence Kenakin, professor at the department of pharmacology at the University of North Carolina’s School of Medicine, explains how the concept of receptors has evolved over the last 10 years and the implications for drug discovery. It was the topic of a recent conference he gave at the NEOMED Institute. “For […]

Thrasos Therapeutics monte blog

(audio) Kidney diseases: a $21M series D financing for Thrasos Therapeutics!

Montreal (Canada) : This week, Thrasos Therapeutics, headquartered in the NÉOMED Institute, raised a $21 million series D financing lead by BDC Capital, a new investor, and SR One. Other current investors (Advanced Technology Ventures, Fonds de solidarité FTQ, Lumira Capital, MP Healthcare Venture Management, Pappas Ventures and SW Co) also participated in the operation. […]

Helmut Thomas

(audio-EN) Macrocycles: Cyclenium Pharma to raise $5 to $7M

Montreal (QUEBEC) – Founded in 2013 by former researchers of Tranzyme Pharma, one of the pioneering companies exploring small molecule macrocycles for drug discovery, Cyclenium Pharma a NÉOMED resident company, takes over the mission. This new-born start-up lead by its CEO and president Helmut Thomas, is building a screening library to produce more than 20,000 […]

test 2 BioAuxilium - Jaime Padros

(audio-EN) BioAuxilium capitalizes on its work with the Montreal Diabetes Research Center

Montreal (QUEBEC) – How to find partners when you’re a 1-year brand new R&D services provider in assay development? Jaime Padrós, president of BioAuxilium, a NÉOMED resident company, has the answer! The leader and its team attend most business conventions taking place in Montreal and the US, and travel to the Boston region on a […]

Arshad Jilani

(audio-EN) Progeneca welcomes its very first customers

Montreal (QUEBEC) – After a long time working in drug discovery, Dr. Arshad Jilani, CEO, has decided in 2012 to take on a new mission: providing R&D services at a reasonable cost for small and large biotech companies, and build its own start-up, Progeneca. After only 2 years, Progeneca, a NÉOMED resident company, has already entered into […]